Levoketoconazole
Tier C — Watch / tradeLevoketoconazole
Targets：CYP11B1, CYP11A1, CYP17A1
Brand：Recorlev, NormoCort
Indications (approved)：Cushing's syndrome
Regional status
Factories producing this API1
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
1 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates2 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| LEVOK-001 | 2234-16-4 | 1-(2,4-dichlorophenyl)ethanone |
| LEVOK-002 | 2631-72-3 | 2-bromo-1-(2,4-dichlorophenyl)ethanone |
| LEVOK-003 | - | ((2S,4S)-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate |
| LEVOK-004 | 67914-60-7 | 1-(4-(4-hydroxyphenyl)piperazin-1-yl)ethanone |
| LEVOK-005 | 142128-65-2 | 1-(4-(4-(((2S,4R)-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethanone |
| Code | CAS No. | Intermediate |
|---|---|---|
| LEVOK-002 | 2631-72-3 | 2-bromo-1-(2,4-dichlorophenyl)ethanone |
| LEVOK-006 | 57044-24-3 | (R)-4-(chloromethyl)-2,2-dimethyl-1,3-dioxolane |
| LEVOK-007 | 170210-44-3 | (2R,4S)-2-(bromomethyl)-4-(chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolane |
| LEVOK-008 | 170210-38-5 | (2R,4R)-2-(bromomethyl)-4-(chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolane |
| LEVOK-009 | 1207291-61-9 | ((2R,4S)-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl benzoate |
| LEVOK-010 | 170210-39-6 | ((2R,4R)-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl benzoate |
| LEVOK-011 | - | ((2R,4R)-2-((1H-imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl benzoate nitrate |
| LEVOK-012 | 170210-49-8 | ((2S,4R)-2-((1H-imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol |
| LEVOK-013 | 170210-50-1 | ((2S,4S)-2-((1H-imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl methanesulfonate |
| LEVOK-014 | 67914-60-7 | 1-(4-(4-hydroxyphenyl)piperazin-1-yl)ethanone |
Frequently asked questions
What are the approved indications of Levoketoconazole?
Approved indications include: Cushing's syndrome.
When does the Levoketoconazole patent expire?
No public expiry year is available for Levoketoconazole yet; this page updates once verified.
How many synthesis routes are recorded for Levoketoconazole?
2 synthesis routes are recorded; the shortest is 4 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Levoketoconazole intermediates?
All intermediates in Levoketoconazole routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Levoketoconazole intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29